chevron_leftBack
As of 24 April 2025, Xiamen Amoytop Biotech Co., Ltd. has a market cap of $4.1B USD, ranking #3290 globally and #545 in China. It ranks #281 in the Healthcare sector, and #60 in the Biotechnology industry.
Key Stats
Market Cap
$4.1BUSD
29.89B CNY
Enterprise Value
$3.99BUSD
29.09B CNY
Revenue (TTM)
$404.17MUSD
2.95B CNY
EBITDA (TTM)
$149.32MUSD
1.09B CNY
Net Income (TTM)
$120.89MUSD
880.92M CNY
EBITDA Margin
37%
Profit Margin
30%
PE Ratio
34.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Li Sun
open_in_new
Employees
1,960
Founded
1996
Website
amoytop.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.8% | -5% | -9.1% | -9.2% | -9.1% | 14% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688278
厦门特宝生物工程股份有限公司 Class A
ISIN: CNE100003RT3
Shares Out.:
Shares Outstanding:
406.8M1
Shares Float:
138.389M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
73.61 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Xiamen Amoytop Biotech Co., Ltd.
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China. The company provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is based in Xiamen, China.
